Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Surface Oncology IncfiledCriticalSurface Oncology Inc
Publication of AR120094A1publicationCriticalpatent/AR120094A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
La presente descripción se refiere a anticuerpos anti-IL-27 y partes de unión a antígeno de estos. La descripción también se refiere a métodos para tratar o mejorar uno o más síntomas de una enfermedad, como el cáncer, mediante la administración de los anticuerpos o la parte de unión a antígeno de estos. La descripción también se refiere a métodos para detectar la IL-27, por ejemplo, en un sujeto o una muestra.The present description relates to anti-IL-27 antibodies and antigen-binding portions thereof. The description also relates to methods of treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or the antigen-binding portion thereof. The description also relates to methods for detecting IL-27, for example, in a subject or sample.
ARP200102673A2019-09-252020-09-25
ANTI-IL-27 ANTIBODIES AND THEIR USES
AR120094A1
(en)